2020;25(5):e12725
doi: 10.3389/fmolb.2025.1639327 Received 07 June 2025 Accepted 04 July 2025 Published 22 July 2025 Volume 12 - 2025 Edited by Venkaiah Betapudi, United States Department of Health and Human Services, United States Reviewed by Anderson Oliveira Souza, Federal University of Mato Grosso, Brazil Raffaella Scanga, University of Calabria, Italy Danish Idrees, University of Iowa Healthcare, United States Rahul Patil, Augusta State University, United States Updates Copyright 2025 Seneff and Kyriakopoulos
CV corresponding to each type of QC samples was calculated
The -enatides are short-acting and primarily decrease postprandial (post-meal) blood glucose, with limited impact on fasting glucose
[3] This is an animal study, so it demonstrates how probiotics can raise GLP-1 rather than proving a specific weight-loss result in people, but it establishes the pathway cleanly: more of the right bacteria means more butyrate, and more butyrate means more GLP-1